MYRIAD GENETICS, INC. Business Acquisition, Pro Forma Earnings Per Share, Diluted
MYRIAD GENETICS, INC. (MYGN) reported Business Acquisition, Pro Forma Earnings Per Share, Diluted of $0.09 per share for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-08.
Discontinued › Income Statement › Earnings Per Share
us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted · last filed 2019-05-08
- MYRIAD GENETICS, INC. business acquisition, pro forma earnings per share, diluted for the quarter ending 2019-03-31 was $0.09.
- MYRIAD GENETICS, INC. business acquisition, pro forma earnings per share, diluted for the quarter ending 2018-12-31 was $0.03, a 83.33% decline year-over-year.
- MYRIAD GENETICS, INC. business acquisition, pro forma earnings per share, diluted for the quarter ending 2018-09-30 was $0.11, a 86.90% decline year-over-year.
- MYRIAD GENETICS, INC. business acquisition, pro forma earnings per share, diluted for the quarter ending 2018-03-31 was -$0.02, a 133.33% decline year-over-year.
- MYRIAD GENETICS, INC. business acquisition, pro forma earnings per share, diluted for fiscal 2017 was $0.02, a 97.70% decline from fiscal 2016.
- MYRIAD GENETICS, INC. business acquisition, pro forma earnings per share, diluted for fiscal 2016 was $0.87, a 19.44% decline from fiscal 2015.
- MYRIAD GENETICS, INC. business acquisition, pro forma earnings per share, diluted for fiscal 2015 was $1.08, a 45.73% decline from fiscal 2014.
- MYRIAD GENETICS, INC. business acquisition, pro forma earnings per share, diluted for fiscal 2014 was $1.99, a 53.08% increase from fiscal 2013.
| Period end | Business Acquisition, Pro Forma Earnings Per Share, Diluted 3 month | Business Acquisition, Pro Forma Earnings Per Share, Diluted 3 month as first filed | Business Acquisition, Pro Forma Earnings Per Share, Diluted 6 month | Business Acquisition, Pro Forma Earnings Per Share, Diluted 6 month as first filed | Business Acquisition, Pro Forma Earnings Per Share, Diluted 9 month | Business Acquisition, Pro Forma Earnings Per Share, Diluted 9 month as first filed | Business Acquisition, Pro Forma Earnings Per Share, Diluted 12 month | Business Acquisition, Pro Forma Earnings Per Share, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2019-03-31 | $0.09 10-Q · filed 2019-05-08 | $0.24 10-Q · filed 2019-05-08 | ||||||
| 2018-12-31 | $0.03 10-Q · filed 2019-02-06 | $0.15 10-Q · filed 2019-02-06 | ||||||
| 2018-09-30 | $0.11 10-Q · filed 2018-11-07 | |||||||
| 2018-03-31 | -$0.02 10-Q · filed 2019-05-08 | $0.16 10-Q · filed 2018-05-09 | $0.99 10-Q · filed 2019-05-08 | $1.74 10-Q · filed 2018-05-09 | ||||
| 2017-12-31 | $0.18 10-Q · filed 2019-02-06 | $0.45 10-Q · filed 2018-02-07 | $1.00 10-Q · filed 2019-02-06 | $1.59 10-Q · filed 2018-02-07 | ||||
| 2017-09-30 | $0.84 10-Q · filed 2018-11-07 | $1.15 10-Q · filed 2017-11-08 | ||||||
| 2017-06-30 | $0.02 10-K · filed 2018-08-24 | $0.04 10-K · filed 2017-08-09 | ||||||
| 2017-03-31 | $0.06 10-Q · filed 2018-05-09 | -$0.13 10-Q · filed 2018-05-09 | ||||||
| 2016-12-31 | $0.09 10-Q · filed 2018-02-07 | -$0.19 10-Q · filed 2018-02-07 | ||||||
| 2016-09-30 | -$0.28 10-Q · filed 2017-11-08 | |||||||
| 2016-06-30 | $0.87 10-K · filed 2018-08-24 | $0.98 10-K · filed 2017-08-09 | ||||||
| 2016-03-31 | $0.32 10-Q · filed 2017-05-03 | $0.91 10-Q · filed 2017-05-03 | ||||||
| 2015-12-31 | $0.32 10-Q · filed 2017-02-08 | $0.59 10-Q · filed 2017-02-08 | ||||||
| 2015-09-30 | $0.27 10-Q · filed 2016-11-02 | |||||||
| 2015-06-30 | $1.08 10-K · filed 2015-08-12 | |||||||
| 2015-03-31 | $0.29 10-Q · filed 2015-05-06 | $0.82 10-Q · filed 2015-05-06 | ||||||
| 2014-12-31 | $0.32 10-Q · filed 2015-02-04 | $0.53 10-Q · filed 2015-02-04 | ||||||
| 2014-09-30 | $0.21 10-Q · filed 2014-11-05 | |||||||
| 2014-06-30 | $1.99 10-K · filed 2015-08-12 | |||||||
| 2014-03-31 | $0.38 10-Q · filed 2015-05-06 | $1.56 10-Q · filed 2015-05-06 | ||||||
| 2013-12-31 | $0.62 10-Q · filed 2015-02-04 | $1.17 10-Q · filed 2015-02-04 | ||||||
| 2013-09-30 | $0.55 10-Q · filed 2014-11-05 | |||||||
| 2013-06-30 | $1.30 10-K · filed 2014-08-13 | |||||||
| 2013-03-31 | $0.35 10-Q · filed 2014-05-07 | $0.90 10-Q · filed 2014-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |